Wed.Mar 27, 2024

article thumbnail

Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments

STAT

For years, researchers have been hopeful they could get under the hood of multiple sclerosis. The neurological condition shows up in over 2.5 million people around the world, but it doesn’t always look the same. If science could point its light in just the right way, patients might be sorted into disease subgroups, and treated more successfully depending on their kind of MS.

Immunity 351
article thumbnail

Takeda plots ‘unprecedented patient diversity’ for psoriasis drug that could compete with BMS

PharmaVoice

Ahead of more guidance from the FDA on diversity in clinical trials, Takeda is aiming to beat industry standards.

147
147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Gut bacteria could play role in kidney autoimmune disease, study shows

STAT

Right now, inside your digestive tract, there are trillions of bacteria, fungi, and viruses that form a tiny universe known as the gut microbiome. New research shows that certain bacteria can alter antibodies so much that they’re unrecognizable to the body’s defenses — potentially leading to immune friendly fire. The bacteria, called Akkermansia muciniphila, can strip the sugar coating from IgA antibodies, immune proteins abundant in the gut.

Immunity 343
article thumbnail

Building the patient experience into observational studies produces stronger real-world evidence

pharmaphorum

Incorporating the patient experience into observational studies can enhance the quality of real-world evidence gathered. Learn how patient-centred approaches can lead to stronger research outcomes.

119
119
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

The Food is Medicine movement originators are trying to standardize medically tailored meals

STAT

WASHINGTON — Food corporations, grocery stores, and even tech companies are claiming they are a part of the growing effort to use food to treat medical conditions. Now, the nonprofits that pioneered the work want to standardize it. The Food is Medicine Coalition, an association of community-based nonprofit food providers, released a 32-page accreditation standard, which was shared first with STAT Wednesday.

article thumbnail

No 'blurred lines' between pharmacy professionals, officials tell inquiry

The Pharmacist

Government and NHS officials have refuted a suggestion that the lines between pharmacists and pharmacy technicians are being 'blurred'. Speaking at the Health and Social Care (HSCC)’s pharmacy inquiry this week, Birmingham (Erdington) MP Paulette Hamilton said she was ‘concerned’ about the way pharmacy technicians were being represented to the public, and claimed some were […] The post No 'blurred lines' between pharmacy professionals, officials tell inquiry appeared first on The

More Trending

article thumbnail

Japan clears first CLDN18.2 drug, Astellas’ Vyloy

pharmaphorum

Astellas has become the first drugmaker to bring a claudin 18.2 (CLDN18.2) targeted therapy to regulatory approval, getting a green light in Japan for Vyloy as a treatment for stomach cancer. The Ministry of Health, Labour and Welfare (MHLW) has cleared Vyloy (zolbetuximab) for use in combination with chemotherapy for patients with HER2-negative CLDN18.2-positive advanced or recurrent gastric cancer that cannot be treated with surgery.

article thumbnail

Brazil’s plan for low-cost CAR-Ts

STAT

New biotech newsletter launching tomorrow. Don’t miss out. Good morning, everyone. Damian here with the details on a potentially major drug approval, an idea to make CAR-T more equitable, and the slow launch of a gene therapy.

article thumbnail

Brainomix AI shows its worth in AZ pulmonary fibrosis trial

pharmaphorum

Brainomix's e-Lung AI can accurately identify idiopathic pulmonary fibrosis patients most likely to progress and could inform the clinical trial design for new therapies

121
121
article thumbnail

STAT+: AstraZeneca sues Arkansas over the role of pharmacies in a federal discount drug program

STAT

AstraZeneca filed a lawsuit seeking to block an Arkansas law that requires the company to ship its medicines to any pharmacy working with hospitals participating in a controversial federal discount program. The move comes less than a month after a U.S. appeals court upheld the same law, but the company is trying to make a different argument in hopes of stopping other states from pursuing similar laws.

Hospitals 282
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Veeda Clinical Research acquires Heads, a European CRO

Express Pharma

Veeda Clinical Research has acquired Heads, a privately held European CRO, which specialises in conducting clinical trials in oncology. Established in 2010, Heads has operational presence in 25 multiple strategically important locations across Europe, North America and Asia Pacific region. Veeda expands its reach to major geographies and adds capabilities of late-sta. ge clinical trial execution with strong focus on oncology with this acqusition The acquisition provides Heads a strong operationa

111
111
article thumbnail

Women in Science: Follow your passion and you’ll get to where you’re meant to be - Jennifer Visser-Rogers

Outsourcing Pharma

From math hater to a leader in clinical data, itâs been a long journey for Jennifer Visser-Rogers, vice president for statistical research and consultancy at Phastar.

108
108
article thumbnail

Leveraging Digital Tools to Optimize Manufacturing Processes

Pharmaceutical Commerce

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses how companies can leverage digital tools like artificial intelligence and machine learning to optimize manufacturing processes and ensure efficient production.

102
102
article thumbnail

Understanding the politics of drug pricing in the United States

pharmaphorum

Brandon Newman, CEO of healthcare analytics firm Xevant, joins host Jonah Comstock on today’s episode of the pharmaphorum podcast.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Episode 908: Finally, All the VTE Recommendations In One Document!

Pharmacy Joe

In this episode, I’ll discuss the consolidated CHEST guidelines on antithrombotic therapy for venous thromboembolism disease. Episode 908: Finally, All the VTE Recommendations In One Document! Subscribe on iTunes , Android , or Stitcher The CHEST guidelines on venous thromboembolism disease are an invaluable resource, but one flaw that has persisted since 2016 has made referencing the guidelines awkward and inconvenient.

article thumbnail

Strong growth for Sweden’s pharmaceutical exports

European Pharmaceutical Review

According to SwedenBIO, Sweden‘s life sciences industry is witnessing a continued increase in export values. Based on statistics from Statistics Sweden, at SEK 152.5 billion, exports of pharmaceuticals reached a total of 7.3 percent of Sweden’s total export value. SwedenBIO highlighted that this is an almost 10 percent increase since 2022. Value of Swedish pharmaceutical exports Swedish pharmaceuticals exports are currently “significantly larger” than exports of iron and steel.

article thumbnail

Prioritizing women, promoting diversity and a patient-first approach - how does CTM do it?

Outsourcing Pharma

OSP senior editor, Liza Laws, took some time at SCOPE 2024 in Orlando earlier in the year to speak with two female-focused members of the Clinical Trials Media (CTM) team, Katherine Seay and Veronica Berk to find out how.

98
article thumbnail

Dissatisfaction with NHS ‘at record high’

pharmaphorum

More than half (52%) of people who participated in a major survey of the GB public were dissatisfied with the NHS, as staff shortages, strikes, and record waiting lists take their toll. The results from the annual British Social Attitudes (BSA) survey came from 3,000 people interviewed across England, Scotland, and Wales and showed that less than a quarter (24%) were satisfied with the health service, a 29 percentage drop in three years.

110
110
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

PhaSER Biomedical and the Sanders TDI partner for clinical drug discovery research

Pharma Times

PhaSER will provide 8HUM mouse models for the TDI to accelerate a pipeline of novel therapeutic targets

125
125
article thumbnail

Does the Passing of a No Behavioral Health-Cost Sharing Law Have Any Bearing on Spending?

Pharmaceutical Commerce

A study investigates how a New Mexico law can impact patients’ out-of-pocket costs surrounding mental health and substance use disorder medications.

105
105
article thumbnail

Drug safety driving pyrogen testing market expansion

European Pharmaceutical Review

A report by Allied Market Research has predicted that the global pyrogen testing market will value $3.3 billion by 2032. The market is predicted to grow at a CAGR of 8.2 percent from 2023 to 2032, according to the research. Drivers of the pyrogen testing market Increased R&D activities within the pharmaceutical and biopharmaceutical sector and a focus on biologics, were reported to hold significant growth opportunities for the pyrogen testing market.

94
article thumbnail

Omega-3s and Stress Reduction: WellPure 1300 EC Boosts Calm

Welltopia Pharmacy

Omega-3s and Stress Reduction: Unveiling the Calming Power of WellPure Omega 1300 EC Omega-3s and Stress Reduction In the whirlwind

111
111
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Reuters Pharma USA 2024 - Day 2

pharmaphorum

Get live coverage of the latest updates and developments from Day 2 of Reuters Pharma USA 2024. Stay informed with real-time news and insights from the event.

114
114
article thumbnail

LifeArc provides £750,000 fund for clinical trial to treat neuroferritinopathy

Pharma Times

The progressive and incurable brain disorder currently affects approximately 100 patients worldwide

119
119
article thumbnail

Teva UK partners Closed Loop on personalised medicine

pharmaphorum

Teva UK has joined forces with techbio company Closed Loop Medicine to develop digital companions for pharma products that could provide personalised medicine

105
105
article thumbnail

European study finds popular ALS drug ineffective

BioPharma Dive

The failure of a medicine known as TUDCA is yet another disappointment for ALS patients, as it comes just after Amylyx’s therapy Relyvrio proved unsuccessful in confirmatory testing.

80
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Can psychedelics with shorter yet intense experiences cure people with alcohol dependence?

Outsourcing Pharma

In an exciting collaboration, modern mental health company, Clerkenwell Health, and Beckley Psytech, a clinical-stage biotechnology company, have launched a phase 2a study aimed at investigating a potential breakthrough treatment for alcohol use disorder (AUD).

71
article thumbnail

Moderna gets Blackstone backing for flu vaccine R&D

BioPharma Dive

An arm of the private equity firm pledged up to $750 million in funding for Moderna’s flu shot development, in exchange for milestones and royalties.

article thumbnail

Shared digital NHS prescribing record could avoid nearly 1 million annual drug errors

World Pharma News

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed, and saving up to 22 lives every year, suggests a modelling study, published online in BMJ Quality & Safety. The figures, which are based on the assumption that such a system could reduce medication errors by at least 10%, and by as much as 50%, could also save £millions for the NHS, say the researchers.

80
article thumbnail

Boundless Bio breaks IPO lull with $100M fundraise

BioPharma Dive

The startup’s performance will test investors’ appetite for early-stage drugmakers, as Boundless has only advanced as far as Phase 1 clinical trials.

75
article thumbnail

Heidelberg Pharma gains FDA ODD for ATAC candidate

Pharmafile

Heidelberg Pharma has announced that it has gained Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for HDP-101 for the treatment of multiple myeloma. The candidate is currently being investigated in a phase 1/2a clinical trial for the treatment of relapsed and refractory multiple myeloma (RRMM). HDP-101 is an antibody-drug conjugate […] The post Heidelberg Pharma gains FDA ODD for ATAC candidate appeared first on Pharmafile.

59